FDA Center for Drug Evaluation & Research Issues Warning Letter to Sourav K. Mishra, M.D./All India Institute of Medical Sciences
May 20, 2026
May 20, 2026
WASHINGTON, May 20 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Sourav K. Mishra, M.D. / All India Institute of Medical Sciences from its Center for Drug Evaluation and Research:
* * *
Recipient: Sourav K. Mishra, M.D., Sourav K. Mishra, M.D. / All India Institute of Medical Sciences, Sijua, Patrapada, Bhubaneswar 751019 Odisha, India
Issuing Office: Center for Drug Evaluation and Re . . .
* * *
Recipient: Sourav K. Mishra, M.D., Sourav K. Mishra, M.D. / All India Institute of Medical Sciences, Sijua, Patrapada, Bhubaneswar 751019 Odisha, India
Issuing Office: Center for Drug Evaluation and Re . . .
